Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Health Industry Watch.
Press releases published on April 22, 2025

HCI Group Sets First Quarter 2025 Earnings Call for Thursday, May 8, 2025, at 4:45 p.m. ET
TAMPA, Fla., April 22, 2025 (GLOBE NEWSWIRE) -- HCI Group, Inc. (NYSE: HCI) will hold a conference call on Thursday, May 8, 2025, at 4:45 p.m. Eastern time to discuss results for the first quarter ended March 31, 2025. Financial results will be issued in a …

O3ai to Host Exclusive 'Lunch and Learn' on Smart Manufacturing Infrastructure
Join us on May 6 for a Lunch & Learn on Smart Manufacturing Infrastructure; IT …

The Oncology Institute of Hope and Innovation Expands Research Partnership with Helios Clinical Across Markets, Enhancing Access to Cutting-Edge Cancer Trials
CERRITOS, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- The Oncology Institute, Inc. (NASDAQ: TOI) (“TOI” or the “Company”), a pioneer in value-based community oncology care, is proud to announce an enterprise-wide expansion of its strategic partnership with …

Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones
Abivax Announces Annual General Meeting Details as Company Advances Toward Key 2025 Value-Driving Milestones Annual General Meeting scheduled for Friday, June 6, 2025, in Paris, France Phase 3 ABTECT induction trials remain on track: enrollment completion …

Sight Sciences Appoints Gary Burbach to its Board of Directors
MENLO PARK, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences, or the Company), an eyecare technology company focused on developing and commercializing innovative, interventional technologies that elevate the …

Elutia to Participate in Chardan’s Trending Issues in Drug Development Conference Series on April 29
SILVER SPRING, Md., April 22, 2025 (GLOBE NEWSWIRE) -- Elutia Inc. (Nasdaq: ELUT) (“Elutia”), a pioneer in drug-eluting biomatrix technologies, today announced that Michelle LeRoux Williams, Ph.D., Elutia’s Chief Scientific Officer, will participate in …

Intuitive Announces First Quarter Earnings
SUNNYVALE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Intuitive (the “Company”) (Nasdaq: ISRG), a global technology leader in minimally invasive care and the pioneer of robotic-assisted surgery, today announced financial results for the quarter ended March …

NurExone Appoints Biotech Industry Leader - Jacob Licht to Lead U.S. Operations and Exo-Top Manufacturing Expansion and Completes Continuance into Ontario
TORONTO and HAIFA, Israel, April 22, 2025 (GLOBE NEWSWIRE) -- NurExone Biologic Inc. (TSXV: NRX) (OTCQB: NRXBF) (FSE: J90) (“NurExone” or the “Company”), a preclinical-stage biotechnology company pioneering regenerative exosomes-based therapies for central …

Longeveron® Issues Letter to Shareholders Highlighting Corporate Strategy, Recent Progress and Key Priorities and Goals for 2025
MIAMI, April 22, 2025 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ: LGVN), a clinical stage regenerative medicine biotechnology company developing cellular therapies for life-threatening and chronic aging-related conditions, today announced that the Company …

Mesmerize honored with 2025 Pharmacy500 award by RXinsider
NEW YORK, NY, April 22, 2025 (GLOBE NEWSWIRE) -- Mesmerize, an MJH Life Sciences® brand and a leader in patient education at the point of care, is proud to announce that it has been named to the prestigious 2025 Pharmacy500, an annual award presented by …

Pacira BioSciences to Present 104-Week Efficacy Data Following a Single Local Administration of PCRX-201 for Patients with Mild to Severe Osteoarthritis of the Knee
-- Poster to be presented at OARSI World Congress on Osteoarthritis -- BRISBANE, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to …

Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors
Abivax Announces Appointment of Dominik Höchli, MD to Board of Directors Industry veteran brings deep immunology expertise ahead of key Phase 3 data readout in ulcerative colitis expected in Q3 2025 PARIS, France, April 22, 2025, 10:00 pm CEST – Abivax SA …

Cytokinetics to Announce First Quarter Results on May 6, 2025
SOUTH SAN FRANCISCO, Calif., April 22, 2025 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled to report first quarter results on May 6, 2025 at 4:00 PM Eastern Time. Following the announcement, Cytokinetics’ …

Digicann Ventures Provides Update Regarding Proposed RTO Transaction
/ Not for distribution to U.S. news wire services or for dissemination in the United States / VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Digicann Ventures Ltd. (“Digicann” or the “Company”) (CSE: DCNN) (OTCPK: AGFAF), a company …

Kidney Recipient (Almost) Free to Live a Normal Life
DuBois, Pennsylvania, April 22, 2025 (GLOBE NEWSWIRE) -- Can you fill your cup with ice at a self-serve drink dispenser? Lisa Lane has to drink her beverage without the commercial ice. Can you take ibuprofen when you have a headache? Lisa Lane has to …

Dr. Sam Speron Marks Over 32 Years in Facial Rejuvenation Practice
Dr. Sam Speron Marks Over 32 Years in Facial Rejuvenation Practice CHICAGO, IL, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- For more than three decades, Dr. Sam Speron and his dedicated team have been quietly transforming lives and redefining …

ESource Corp’s L&D Expert Assistant Sets New Standard in AI-Powered Courseware Development
Up to 93x faster than traditional methods, the ESource L…

Migraine Surgery – Understanding a Path Forward by Dr. Adam Lowenstein MD, FACS Offers Hope
With empathy, clarity, and clinical expertise, Dr. Lowenstein helps readers realize solutions and hope that exists beyond pharmaceuticals and temporary relief. LOS ANGELES, CA, UNITED STATES, April 22, 2025 /EINPresswire.com/ -- A groundbreaking new …

High Content Screening and Imaging Market Set for 8.4% CAGR Through 2029
Boston, April 22, 2025 (GLOBE NEWSWIRE) -- BCC Research reveals in its new report, High Content Screening/Imaging: Technologies and Global Markets, the HCS/I market is projected to reach $5.1 billion by 2029, at a five-year compound annual growth rate ( …

Sirona Biochem Announces Debenture Financing
VANCOUVER, British Columbia, April 22, 2025 (GLOBE NEWSWIRE) -- Sirona Biochem Corp. (TSX-V: SBM) (FSE: ZSB) (OTC: SRBCF) (“Sirona” or the “Company”) is pleased to announce a non-brokered private placement offering of unsecured, convertible debentures (the …